(Q35927910)

11 August 2017

1 reference

title

Emergency treatment in glutaryl-CoA dehydrogenase deficiency (English)

1 reference

11 August 2017

Kölker S

1

1 reference

11 August 2017

Greenberg CR

2

1 reference

11 August 2017

Lindner M

3

1 reference

11 August 2017

Müller E

4

1 reference

11 August 2017

Naughten ER

5

1 reference

11 August 2017

Hoffmann GF

6

1 reference

11 August 2017

publication date

1 January 2004

1 reference

Journal of Inherited Metabolic Disease

11 August 2017

published in

1 reference

11 August 2017

volume

27

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

893-902

1 reference

https://scigraph.springernature.com/pub.10.1023/b:boli.0000045774.51260.ea

11 August 2017

exact match

0 references

cites work

Assessment of energy expenditure in metabolic disorders

1 reference

12 December 2020

Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids

1 reference

12 December 2020

Resting energy expenditure in disorders of propionate metabolism.

1 reference

12 December 2020

Glutaric aciduria type I and kynurenine pathway metabolites: a modified hypothesis

1 reference

12 December 2020

Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1.

1 reference

12 December 2020

Emergency management of inherited metabolic diseases

1 reference

12 December 2020

Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity

1 reference

12 December 2020

Maintenance treatment of glutaryl-CoA dehydrogenase deficiency.

1 reference

12 December 2020

Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada

1 reference

12 December 2020

Magnetic resonance imaging of the brain in glutaric acidemia type I: a review of the literature and a report of four new cases with attention to the basal ganglia and imaging technique

1 reference

12 December 2020

Glutaric aciduria type I: outcome in the Republic of Ireland

1 reference

12 December 2020

Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain

1 reference

12 December 2020

Type I glutaric aciduria, part 1: natural history of 77 patients

1 reference

12 December 2020

Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency

1 reference

12 December 2020

Maple syrup urine disease--therapeutic use of insulin in catabolic states

1 reference

12 December 2020

Modulation of glutamatergic and GABAergic neurotransmission in glutaryl-CoA dehydrogenase deficiency

1 reference

12 December 2020

Animal models for glutaryl-CoA dehydrogenase deficiency

1 reference

12 December 2020

Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1.

1 reference

12 December 2020

Glutaric aciduria type I: value of diffusion-weighted magnetic resonance imaging for diagnosing acute striatal necrosis

1 reference

12 December 2020

Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency

1 reference

12 December 2020

CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients

1 reference

12 December 2020

Neuroimaging findings in glutaric aciduria type 1

1 reference

12 December 2020

Treatment of the acute crisis in maple syrup urine disease

1 reference

12 December 2020

Prevention of cerebral palsy in glutaric aciduria type 1 by dietary management

1 reference

12 December 2020

Glutaryl-CoA Dehydrogenase Deficiency in Spain: Evidence of Two Groups of Patients, Genetically, and Biochemically Distinct

1 reference

12 December 2020

Neuroradiological findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency).

1 reference

12 December 2020

Vascular dysfunction as an additional pathomechanism in glutaric aciduria type I.

1 reference

12 December 2020

10.1023/B:BOLI.0000045774.51260.EA

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

1027839006

0 references

1 reference